Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.
Source:http://linkedlifedata.com/resource/pubmed/id/12488405
J. Clin. Oncol.
2002
Dec
15
20
24
4621-7
